UBS Group AG - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,248
-44.8%
1,693
-49.3%
0.00%
Q2 2023$9,510
-12.9%
3,337
+20.4%
0.00%
Q1 2023$10,922
-46.8%
2,772
-46.5%
0.00%
Q4 2022$20,532
-33.8%
5,185
+56.2%
0.00%
Q3 2022$31,000
+416.7%
3,320
+226.8%
0.00%
Q2 2022$6,000
-14.3%
1,016
-1.5%
0.00%
Q4 2021$7,000
+133.3%
1,031
+113.5%
0.00%
Q2 2021$3,000
-96.2%
483
-96.4%
0.00%
Q1 2021$78,000
-20.4%
13,499
-7.8%
0.00%
Q4 2020$98,000
-19.0%
14,646
-11.6%
0.00%
Q3 2020$121,000
+137.3%
16,560
+22.7%
0.00%
Q2 2020$51,000
+104.0%
13,4990.0%0.00%
Q1 2020$25,00013,4990.00%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
VHCP Management III, LLC 2,066,529$38,541,00023.79%
Novo Holdings A/S 2,674,470$49,879,0008.54%
ACUTA CAPITAL PARTNERS, LLC 369,500$6,891,0004.97%
RTW INVESTMENTS, LP 3,521,856$63,819,0003.80%
Boxer Capital, LLC 1,102,194$20,556,0001.49%
Ghost Tree Capital, LLC 235,000$4,383,0001.12%
VHCP Management II, LLC 148,560$2,771,0001.06%
Tekla Capital Management LLC 46,940$812,0000.04%
Baker Brothers Advisors 266,667$4,973,0000.03%
Zimmer Partners, LP 160,000$2,984,0000.03%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders